BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17302188)

  • 21. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
    Saslow D; Castle PE; Cox JT; Davey DD; Einstein MH; Ferris DG; Goldie SJ; Harper DM; Kinney W; Moscicki AB; Noller KL; Wheeler CM; Ades T; Andrews KS; Doroshenk MK; Kahn KG; Schmidt C; Shafey O; Smith RA; Partridge EE; ; Garcia F
    CA Cancer J Clin; 2007; 57(1):7-28. PubMed ID: 17237032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications and efficacy of the human papillomavirus vaccine.
    Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
    Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Human papillomavirus vaccines].
    Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
    Maver PJ; Poljak M
    Vaccine; 2018 Aug; 36(36):5416-5423. PubMed ID: 28801154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and other milestones for human papillomavirus vaccine introduction.
    Pagliusi SR; Teresa Aguado M
    Vaccine; 2004 Dec; 23(5):569-78. PubMed ID: 15630792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV vaccines to prevent cervical cancer and genital warts: an update.
    Dochez C; Bogers JJ; Verhelst R; Rees H
    Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against human papillomavirus.
    Lin YY; Alphs H; Hung CF; Roden RB; Wu TC
    Front Biosci; 2007 Jan; 12():246-64. PubMed ID: 17127297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
    Tang J; Li M; Zhao C; Shen D; Liu L; Zhang X; Wei L
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harnessing the power of prevention: human papillomavirus vaccines.
    Mayeaux EJ
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
    Monsonego J
    Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
    Dillner J; Brown DR
    Expert Rev Mol Med; 2004 Apr; 6(9):1-21. PubMed ID: 15096282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in human papillomavirus therapeutic vaccine].
    Liu B; Zhao QZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):685-90. PubMed ID: 18051729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
    Bornstein J
    Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.